Literature DB >> 11313006

The immunology of Epstein-Barr virus infection.

D J Moss1, S R Burrows, S L Silins, I Misko, R Khanna.   

Abstract

Epstein-Barr virus is a classic example of a persistent human virus that has caught the imagination of immunologists, virologists and oncologists because of the juxtaposition of a number of important properties. First, the ability of the virus to immortalize B lymphocytes in vitro has provided an antigen presenting cell in which all the latent antigens of the virus are displayed and are available for systematic study. Second, the virus presents an ideal system for studying the immune parameters that maintain latency and the consequences of disturbing this cell-virus relationship. Third, this wealth of immunological background has provided a platform for elucidating the role of the immune system in protection from viral-associated malignancies of B cell and epithelial cell origin. Finally, attention is now being directed towards the development of vaccine formulations which might have broad application in the control of human malignancies.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11313006      PMCID： PMC1088439          DOI： 10.1098/rstb.2000.0784

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN： 0962-8436            Impact factor:   6.237


  108 in total

1.  Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3.

Authors:  S R Burrows; J Gardner; R Khanna; T Steward; D J Moss; S Rodda; A Suhrbier
Journal:  J Gen Virol       Date:  1994-09       Impact factor: 3.891

Review 2.  Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.

Authors:  A B Rickinson; D J Moss
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 3.  The molecular basis of allorecognition.

Authors:  L A Sherman; S Chattopadhyay
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

4.  Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoire.

Authors:  S R Burrows; S L Silins; S M Cross; C A Peh; M Rischmueller; J M Burrows; S L Elliott; J McCluskey
Journal:  Eur J Immunol       Date:  1997-01       Impact factor: 5.532

5.  Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

Authors:  G Pantaleo; J F Demarest; H Soudeyns; C Graziosi; F Denis; J W Adelsberger; P Borrow; M S Saag; G M Shaw; R P Sekaly
Journal:  Nature       Date:  1994-08-11       Impact factor: 49.962

6.  Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patients.

Authors:  C Pouteil-Noble; R Ecochard; G Landrivon; A Donia-Maged; J C Tardy; S Bosshard; S Colon; H Betuel; M Aymard; J L Touraine
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

7.  HLA matching: identification of permissible HLA mismatches.

Authors:  E Maruya; S Takemoto; P I Terasaki
Journal:  Clin Transpl       Date:  1993

8.  Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line.

Authors:  R Khanna; S R Burrows; V Argaet; D J Moss
Journal:  Int Immunol       Date:  1994-04       Impact factor: 4.823

9.  An Epstein-Barr virus-associated superantigen.

Authors:  N Sutkowski; T Palkama; C Ciurli; R P Sekaly; D A Thorley-Lawson; B T Huber
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

10.  An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.

Authors:  S R Burrows; R Khanna; J M Burrows; D J Moss
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307
View more
  14 in total

1.  Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes.

Authors:  R S Midgley; A I Bell; D J McGeoch; A B Rickinson
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

2.  Infection frequency of Epstein-Barr virus in subgingival samples from patients with different periodontal status and its correlation with clinical parameters.

Authors:  Yan-min Wu; Jie Yan; Li-li Chen; Wei-lian Sun; Zhi-yuan Gu
Journal:  J Zhejiang Univ Sci B       Date:  2006-11       Impact factor: 3.066

3.  CD40 engagement on dendritic cells, but not on B or T cells, is required for long-term control of murine gammaherpesvirus 68.

Authors:  Francesca Giannoni; Ashley Shea; Chandra Inglis; Lian Ni Lee; Sally R Sarawar
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

4.  Development of an epitope panel for consistent identification of antigen-specific T-cells in humans.

Authors:  Andreas Fløe; Caroline Løppke; Ole Hilberg; Christian Wejse; Liselotte Brix; Kivin Jacobsen
Journal:  Immunology       Date:  2017-07-03       Impact factor: 7.397

5.  Cytolytic mechanisms and T-cell receptor Vbeta usage by ex vivo generated Epstein-Barr virus-specific cytotoxic T lymphocytes.

Authors:  Victoria J Vanhoutte; Karen A McAulay; Erin McCarrell; Marc Turner; Dorothy H Crawford; Tanzina Haque
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

6.  Altered CD8(+) T cell immunodominance after vaccinia virus infection and the naive repertoire in inbred and F(1) mice.

Authors:  Inge E A Flesch; Wai-Ping Woo; Yang Wang; Vijay Panchanathan; Yik-Chun Wong; Nicole L La Gruta; Tania Cukalac; David C Tscharke
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

7.  Correlation between infections with different genotypes of human cytomegalovirus and Epstein-Barr virus in subgingival samples and periodontal status of patients.

Authors:  Yan-Min Wu; Jie Yan; David M Ojcius; Li-Li Chen; Zhi-Yuan Gu; Jian-Ping Pan
Journal:  J Clin Microbiol       Date:  2007-09-05       Impact factor: 5.948

8.  HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection.

Authors:  Karen A McAulay; Craig D Higgins; Karen F Macsween; Annette Lake; Ruth F Jarrett; Faye L Robertson; Hilary Williams; Dorothy H Crawford
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

9.  Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge.

Authors:  Junji Sashihara; Yo Hoshino; J Jason Bowman; Tammy Krogmann; Peter D Burbelo; V McNeil Coffield; Kurt Kamrud; Jeffrey I Cohen
Journal:  PLoS Pathog       Date:  2011-10-20       Impact factor: 6.823

10.  Expansion and Adoptive Transfer of Human Vδ2+ T Cells to Assess Antitumor Effects In Vivo.

Authors:  Akshat Sharma; Nicholas A Zumwalde; Jenny E Gumperz
Journal:  Methods Mol Biol       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.